Effects of mefloquine on Ca2+ uptake and release by dog brain microsomes

Arch Int Pharmacodyn Ther. 1996 May-Jun;331(3):221-31.

Abstract

The effects of the antimalarial drug, mefloquine, on the uptake and release of Ca2+ by crude microsomes from dog brain were investigated using a spectrophotometric method. Mefloquine inhibited the inositol-1,4,5-phosphate (IP3)-induced Ca2+ release with an IC50 of 42 microM, but was a weaker inhibitor of the uptake of Ca2+ into the vesicles (IC50: 272 microM). These effects of mefloquine are in contrast to its actions on Ca2+ uptake and release by skeletal muscle microsomes, where its predominant effect was seen to be the inhibition of Ca2+ uptake into the vesicles. Mefloquine was found to be more potent than quinine as a specific inhibitor of Ca2+ release from IP3-sensitive stores in dog brain microsomes. The possibility of the drug affecting cellular IP3-linked signal transduction processes should be considered.

MeSH terms

  • Animals
  • Antimalarials / pharmacology*
  • Brain / drug effects*
  • Brain / metabolism
  • Calcium / metabolism*
  • Dogs
  • Inositol 1,4,5-Trisphosphate / administration & dosage
  • Inositol 1,4,5-Trisphosphate / antagonists & inhibitors
  • Mefloquine / pharmacology*
  • Microsomes / drug effects
  • Quinine / pharmacology

Substances

  • Antimalarials
  • Inositol 1,4,5-Trisphosphate
  • Quinine
  • Calcium
  • Mefloquine